Table 1.
Mean levels of TGF-β, IL-4 and bFGF tissue expression and mean levels of myofibroblast α-SMA and fibroblast telomerase expression in each studied area. For tissue expression, all immunostained cells were considered to be positive. For fibroblasts expression, only immunostained cells with a morphological similarity to fibroblasts (thin cells with an elongated shape) were considered to be positive. Abbreviations: U, unaffected areas; C, collapsed areas; MF, mural fibrosis areas; and H, honeycombing areas.
Marker | Unaffected (U) | Collapsed (C) | Mural Fibrosis (MF) | Honeycombing (H) | Statistical analysis |
TGF-β | 9.19±2.16 | 19.63±5.70 | 16.48±4.11% | 17.08±4.52% | U × C: p = 0.01*U × MF: p = 0.01*U × H: p = 0.01*C × MF: p = 0.13C × H: p = 0.51MF × H: p = 0.22 |
IL-4 | 0.0±0.0 | 3.27±5.48% | 14.03±6.02% | 7.91±4.04% | C × MF: p<0.01*C × H: p<0.01*MF × H: p<0.01* |
bFGF | 10.57±6.24 | 15.50±4.99% | 11.62±3.62% | 12.21±4.68% | U × C: p = 0.01*U × MF: p = 0.72U × H: p = 0.31C × MF: p = 0.02*C × H: p = 0.03*MF × H: p = 0.65 |
Myofibroblast α-SMA | 0.0±0.0 | 9.02±2.92% | 5.25±5.14% | 5.21±2.13% | C × MF: p<0.01*C × H: p<0.92MF × H: p<0.01* |
FibroblastTelomerase | 0.0±0.0 | 6.76±1.31% | 5.26±1.13% | 5.01±1.14% | C × MF: p = 0.04*C × H: p = 0.03*MF × H: p = 0.19 |
Area (mean ± Standard Deviation).